Newser on MSN2h
New Painkiller May Be 'Landmark Development'
The FDA is expected to grant approval to a new pain medication with big potential—mainly because it's a non-opioid and is ...
Impacts18h
Generative AI: Revolutionizing Industries
Introduction to Generative AI Generative AI refers to algorithms that can create new content, including text, images, music, ...
Business Wire22h
Arrowhead Pharmaceuticals Announces Acceptance of New Drug Application by U.S. FDA of Plozasiran for the Treatment of Familial Chylomicronemia Syndrome
Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that the U.S. Food and Drug Administration (FDA) has accepted ...